Accessibility Menu
 
Argenx Se logo

Argenx Se

(NASDAQ) ARGX

Current Price$676.61
Market Cap$41.93B
Since IPO (2017)+2,865%
5 Year+131%
1 Year+11%
1 Month-20%

Argenx Se Financials at a Glance

Market Cap

$41.93B

Revenue (TTM)

$5.49B

Net Income (TTM)

$2.16B

EPS (TTM)

$19.58

P/E Ratio

32.11

Dividend

$0.00

Beta (Volatility)

0.66 (Low)

Price

$676.61

Volume

13,661

Open

$672.89

Previous Close

$676.61

Daily Range

$667.46 - $677.61

52-Week Range

$510.06 - $934.62

ARGX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Argenx Se

Industry

Biotechnology

Employees

1,863

CEO

Tim van Hauwermeiren, EMBA

Headquarters

Amsterdam, 1101EB, NL

ARGX Financials

Key Financial Metrics (TTM)

Gross Margin

89%

Operating Margin

26%

Net Income Margin

33%

Return on Equity

20%

Return on Capital

12%

Return on Assets

13%

Earnings Yield

3.11%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$41.93B

Shares Outstanding

61.88M

Volume

13.66K

Short Interest

0.00%

Avg. Volume

366.45K

Financials (TTM)

Gross Profit

$3.71B

Operating Income

$972.46M

EBITDA

$972.46M

Operating Cash Flow

$850.49M

Capital Expenditure

$6.18M

Free Cash Flow

$844.30M

Cash & ST Invst.

$4.44B

Total Debt

$83.49M

Argenx Se Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$2.41B

+319.8%

Gross Profit

$2.15B

+317.8%

Gross Margin

89.26%

N/A

Market Cap

$41.93B

N/A

Market Cap/Employee

$26.22M

N/A

Employees

1,599

N/A

Net Income

$874.92M

+857.1%

EBITDA

$789.10M

+789.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$4.36B

+37.9%

Accounts Receivable

$1.66B

+231.9%

Inventory

$473.53M

+52.5%

Long Term Debt

$72.65M

+373.2%

Short Term Debt

$10.83M

+133.2%

Return on Assets

13.00%

N/A

Return on Invested Capital

11.76%

N/A

Free Cash Flow

$406.90M

+400.9%

Operating Cash Flow

$407.80M

+402.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ALNYAlnylam Pharmaceuticals, Inc.
$308.05+0.45%
HLNHaleon plc
$9.70-2.32%
IDXXIDEXX Laboratories, Inc.
$570.21-1.43%
EWEdwards Lifesciences Corporation
$81.69-0.40%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.62-0.02%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.61+0.00%
ONDSOndas
$10.68-0.02%
IBRXImmunityBio
$7.42-0.21%

Questions About ARGX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.